Home

obvod index pověra ca19 9 tumor marker false positive hlavní Přiblížit Vylučovat

Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future

IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence  Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold  Nanocomposite
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite

The Highest Ever Reported Level of Carbohydrate Antigen 19-9: A Case Report  | Al-Khallaf | Journal of Medical Cases
The Highest Ever Reported Level of Carbohydrate Antigen 19-9: A Case Report | Al-Khallaf | Journal of Medical Cases

Non-malignant causes of CA19.9 elevation (medline research) | Download Table
Non-malignant causes of CA19.9 elevation (medline research) | Download Table

CA19-9 - Wikipedia
CA19-9 - Wikipedia

Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic  Cancer - Gastroenterology
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology

Carbohydrate antigen 19-9 elevation without evidence of malignant or  pancreatobiliary diseases | Scientific Reports
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports

CA 19-9 Antigen - an overview | ScienceDirect Topics
CA 19-9 Antigen - an overview | ScienceDirect Topics

Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer  Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study -  eBioMedicine
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine

Table 1 from Cancer antigens 19-9 and 125 in the differential diagnosis of  pancreatic mass lesions. | Semantic Scholar
Table 1 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar

Prognostic and predictive value of CA 19-9 in locally advanced pancreatic  cancer treated with multiagent induction chemotherapy: results from a  prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)☆ - ESMO Open
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)☆ - ESMO Open

Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder  Bind MK, Mishra RR, Kumar V, Misra V, Singh PA - Indian J Pathol Microbiol
Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder Bind MK, Mishra RR, Kumar V, Misra V, Singh PA - Indian J Pathol Microbiol

The clinical utility of serum CA 19-9 in the diagnosis, prognosis and  management of pancreatic adenocarcinoma: An evidence based appraisal -  Ballehaninna - Journal of Gastrointestinal Oncology
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology

Should I take a Cancer Marker Test? | Positive Bioscience
Should I take a Cancer Marker Test? | Positive Bioscience

Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer  Early Detection - ScienceDirect
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection - ScienceDirect

The clinical utility of serum CA 19-9 in the diagnosis, prognosis and  management of pancreatic adenocarcinoma: An evidence based appraisal -  Ballehaninna - Journal of Gastrointestinal Oncology
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology

CA19-9 - Wikipedia
CA19-9 - Wikipedia

Common benign HPB conditions with associated deranged CA19.9 level |  Download Table
Common benign HPB conditions with associated deranged CA19.9 level | Download Table

Dynamic change of serum CA19–9 levels in benign and malignant patients with  obstructive jaundice after biliary drainage and new correction formulas |  BMC Cancer | Full Text
Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas | BMC Cancer | Full Text

The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice |  Science
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science

Table 1 from Tumor markers in pancreatic cancer: a European Group on Tumor  Markers (EGTM) status report. | Semantic Scholar
Table 1 from Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar

Noninvasive detection of pancreatic ductal adenocarcinoma using the  methylation signature of circulating tumour DNA | BMC Medicine | Full Text
Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA | BMC Medicine | Full Text

CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a  meta-analysis | SpringerLink
CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis | SpringerLink

Persistent elevation of Ca 19-9 and an unexpected finding. A case report |  Cirugía y Cirujanos (English Edition)
Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition)

CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports

Change in CA 19-9 levels after chemoradiotherapy predicts survival in  patients with locally advanced unresectable pancreatic cancer - Yang -  Journal of Gastrointestinal Oncology
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology

Persistent increase of carbohydrate antigen 19‐9 with an unknown reason: A  seven‐year follow‐up case - Zhao - 2022 - Journal of Clinical Laboratory  Analysis - Wiley Online Library
Persistent increase of carbohydrate antigen 19‐9 with an unknown reason: A seven‐year follow‐up case - Zhao - 2022 - Journal of Clinical Laboratory Analysis - Wiley Online Library

Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients
Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients

Tumor Marker:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
Tumor Marker:- Part 7 - CA 125 and CA 19-9 - Labpedia.net